Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Benmelstobart
Anlotinib
Nanfang Hospital, Southern Medical UniversityP3BB (64)
Cetuximab
Colorectal Carcinoma
Shanghai Changzheng HospitalP3BB (64)
Donanemab
Central Nervous System Disorder
Eli Lilly and CompanyP3BB (64)
Elotuzumab
Plasma Cell Myeloma
Hoffmann-La RocheP3BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED ANTIGEN 4) (HUMAN-MUS MUSCULUS MONOCLONAL M3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M3 .KAPPA.-CHAIN, DIMER
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP3BB (64)
Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 ?1-chain), disulfide with human-Mus musculus monoclonal JMT101 ?-chain, dimer
Colorectal Cancer
Shanghai JMT-Bio Inc.P3BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
Systemic-Onset Juvenile Idiopathic Arthritis
Novartis PharmaceuticalsP3BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Estrogen-Receptor Positive Breast Cancer
Dana-Farber Cancer InstituteP3BB (64)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Lung Cancer
University of ChicagoP3BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Relapsing-Remitting Multiple Sclerosis
University Hospital, MontpellierP3BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Myelodysplastic Syndrome
Prelude TherapeuticsP3BB (64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Institute of Hematology & Blood Diseases Hospital, ChinaP3BB (64)
Ipilimumab
Colon Adenocarcinoma
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (64)
Ipilimumab
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical CenterP3BB (64)
Ipilimumab
Uveal Melanoma
Inge Marie SvaneP3BB (64)
Ivonescimab
Colorectal Cancer
UNICANCERP3BB (64)
Ivonescimab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (64)
Ivuxolimab
Cancer
PfizerP3BB (64)
Ixekizumab
Psoriatic Arthritis
NHS Greater Glasgow and ClydeP3BB (64)
Nivolumab
Differentiated Thyroid Carcinoma
ExelixisP3BB (64)
Nivolumab
Anal Margin Squamous Cell Carcinoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Anal Squamous Cell Carcinoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (64)
Nivolumab
Nonpapillary Renal Cell Carcinoma
Fred Hutchinson Cancer CenterP3BB (64)
Showing 451 to 475 of 6,371 assets
PreviousPage 19 of 255Next